L. Tracey

发表

Somatic hypermutation signature in B-cell low-grade lymphomas

Nerea Martínez, Mohit Aggarwal, Juan F. García, 2008, Haematologica.

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome

R. Stallings, A. Davidoff, A. Tivnan, 2012, British Journal of Cancer.

Expression of the NF‐κB targets BCL2 and BIRC5/Survivin characterizes small B‐cell and aggressive B‐cell lymphomas, respectively

Nerea Martínez, Marta Cuadros, Juan F. García, 2005, The Journal of pathology.

Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study.

Juan F. García, M. Piris, I. Spiteri, 2003, Blood.

MicroRNA-184-mediated inhibition of tumour growth in an orthotopic murine model of neuroblastoma.

R. Stallings, A. Davidoff, A. Tivnan, 2010, Anticancer research.

Role of BCR-ABL-Y177 mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors

L. Pfeffer, A. Davidoff, R. Bhatia, 2009, Leukemia.

Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma.

A. Dopazo, M. Piris, J. Dopazo, 2002, The American journal of pathology.

Assessing Interactions for Fixed-Dose Drug Combinations in Tumor Xenograft Studies

A. Davidoff, L. Tracey, Jianrong Wu, 2012, Journal of biopharmaceutical statistics.

A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis.

A. Sánchez-Aguilera, M. Piris, J. Rodríguez-Peralto, 2007, Cancer research.

Tyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomas.

C. Waters, C. Stewart, Jun Shen, 2010, Cancer research.

MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma

R. Stallings, A. Davidoff, P. Buckley, 2011, BMC Cancer.

Identification of genes involved in imatinib resistance in CML: a gene-expression profiling approach

M. Piris, J. Martínez, P. Martínez, 2006, Leukemia.

MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma.

R. Stallings, A. Davidoff, K. Bryan, 2011, Cancer letters.

involved in the TNF signaling pathway : an expression profile study Mycosis fungoides shows concurrent deregulation of multiple genes

Juan F. García, M. Piris, I. Spiteri, 2003 .

Maturation of tumor vasculature by interferon-beta disrupts the vascular niche of glioma stem cells.

A. Davidoff, H. Poppleton, A. Myers, 2010, Anticancer research.

Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma.

A. Dopazo, M. Piris, J. Dopazo, 2002, The American journal of pathology.

Transcriptional Response of T Cells to IFN-α: Changes Induced in IFN-α-Sensitive and Resistant Cutaneous T Cell Lymphoma

M. Piris, I. Spiteri, R. Villuendas, 2004 .

Epithelial-mesenchymal Transition as a Major Determinant a High-throughput Study in Melanoma Identifies Updated Version Material Supplementary Cited Articles Citing Articles E-mail Alerts a High-throughput Study in Melanoma Identifies Epithelial- Mesenchymal Transition as a Major Determinant of Meta

A. Sánchez-Aguilera, M. Piris, J. Rodríguez-Peralto, 2022 .

IFN-β Restricts Tumor Growth and Sensitizes Alveolar Rhabdomyosarcoma to Ionizing Radiation

A. Davidoff, A. Nathwani, M. W. Gaber, 2010, Molecular Cancer Therapeutics.

Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter SNP that alters PARP1 binding and SMARCB1 expression.

M. Relling, W. Evans, Wenjian Yang, 2007, Human molecular genetics.

Transcriptional response of T cells to IFN-alpha: changes induced in IFN-alpha-sensitive and resistant cutaneous T cell lymphoma.

M. Piris, I. Spiteri, R. Villuendas, 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Psoralen plus ultraviolet A ± interferon‐α treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor‐κB and T‐cell receptor pathways

M. Piris, J. Rodríguez-Peralto, P. Ortiz-Romero, 2009, The British journal of dermatology.

Expression of SMARCB 1 modulates steroid sensitivity in human lymphoblastoid cells : identification of a promoter snp that alters PARP 1 binding and SMARCB 1 expression

M. Relling, W. Evans, Wenjian Yang, 2007 .

involved in the TNF signaling pathway : an expression profile study Mycosis fungoides shows concurrent deregulation of multiple genes

Juan F. García, M. Piris, I. Spiteri, 2003 .

IFN-β sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O6-methylguanine DNA methyltransferase expression

L. Pfeffer, A. Davidoff, C. Stewart, 2008, Molecular Cancer Therapeutics.

Treatment of Staphylococcus Aureus with Antibiotic and Quorum-Sensing Inhibitor Combinations Reduces Severity of Keratitis

E. Hume, L. Tracey, N. Kumar, 2017 .

Tyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomas.

C. Waters, C. Stewart, Jun Shen, 2010, Cancer research.